Frontera Therapeutics Funding: $195M Raised, Series B (2022)
Frontera Therapeutics is based in Bedford, United States and Suzhou, China. It has raised $195M in total funding. Latest round: Series B.
Frontera Therapeutics funding overview
Frontera Therapeutics is based in Bedford, United States and Suzhou, China. Frontera Therapeutics has raised $195M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in July 2022. The round record for Frontera Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Boyu Capital, Sequoia China, OrbiMed, Creacion Ventures. 4 distinct backers are named across the disclosed rounds.
Frontera Therapeutics at a glance
Total raised
$195M
Latest round
Series B
Latest round date
July 2022
Headquarters
Bedford, United States and Suzhou, China
Notable investors
Boyu Capital, Sequoia China, OrbiMed, Creacion Ventures
Frequently asked about Frontera Therapeutics funding
How much has Frontera Therapeutics raised?
Frontera Therapeutics has raised $195M in total disclosed funding across the rounds on record.
Who has invested in Frontera Therapeutics?
Boyu Capital, Sequoia China, OrbiMed, Creacion Ventures are named among the investors backing Frontera Therapeutics.
What was the latest Frontera Therapeutics funding round?
The most recent disclosed round is a Series B, announced in July 2022.
Where is Frontera Therapeutics based?
Frontera Therapeutics is based in Bedford, United States and Suzhou, China.
When did Frontera Therapeutics last raise?
The last disclosed Frontera Therapeutics round closed in July 2022 at Series B.
Totals shown for Frontera Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Bedford and the investors behind them below.
